首页 > 最新文献

Advanced Biomedical Research最新文献

英文 中文
Evaluation of Herbal Hair Lotion loaded with Rosemary for Possible Hair Growth in C57BL/6 Mice. 含有迷迭香的中草药洗发液对C57BL/6小鼠毛发生长的影响
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_306_21
Asia Begum, Sandhya S, Anoop Kumar N, Syed S Ali

Background: Rosmarinus officinalis (rosemary) is a common household plant with needle-like leaves and white flowers that belongs to the family Lamiaceae and has various medicinal properties including ailments of hair and scalp, cardiovascular, nervous disorders, etc., In the current work, we have focused on formulation and evaluation of 1% hair lotion incorporated with methanolic extract of R. officinalis.

Materials and methods: The aerial parts of the plant were extracted with methanol and then the nature of phytochemicals were identified by chemical tests. It showed the presence of proteins, amino acids, fats and oils, steroids, glycosides, phenolic compounds, flavonoids, volatile oil, and vitamins. The extract was formulated to a suitable hair lotion and then evaluated for its various quality control parameters. Finally, the lotion was evaluated for hair growth promoting activity on C57BL/6 mice, using water as control and 2% minoxidil hair lotion as standard.

Results: It was observed that the formulated 1% herbal hair lotion passed all the evaluation parameters and showed a significant hair growth promoting activity than the standard drug-treated animals.

Conclusion: Although several researches have been carried out on the rosemary, an investigation on formulation of hair lotion adding the extract of the aerial part of the plant is for the first time. Since our formulation exhibited an excellent activity, it can be well thought out to be an alternative to the commercially available hair growth promoters with a lot of unwanted effects.

背景:迷迭香(Rosmarinus officinalis,迷迭香)是一种常见的家用植物,叶呈针状,花呈白色,属于Lamiaceae,具有多种药用价值,包括头发和头皮疾病、心血管疾病、神经疾病等。在本研究中,我们重点研究了含1% officinalis甲醇提取物的洗发液的配方和评价。材料和方法:用甲醇提取植物的地上部分,通过化学试验鉴定植物化学物质的性质。它显示了蛋白质、氨基酸、油脂、类固醇、糖苷、酚类化合物、类黄酮、挥发油和维生素的存在。将提取液配制成合适的洗发液,并对其各项质量控制参数进行了评价。最后,以水为对照,2%米诺地尔洗发液为标准,评价洗发液对C57BL/6小鼠的促毛活性。结果:1%中草药洗发液通过各项评价指标,与标准药物处理动物相比,具有显著的促毛活性。结论:虽然对迷迭香进行了一些研究,但对加入其地上部分提取物的洗发液配方的研究尚属首次。由于我们的配方表现出良好的活性,它可以很好地被认为是一个替代商业上可用的头发生长促进剂有很多不想要的影响。
{"title":"Evaluation of Herbal Hair Lotion loaded with Rosemary for Possible Hair Growth in C57BL/6 Mice.","authors":"Asia Begum,&nbsp;Sandhya S,&nbsp;Anoop Kumar N,&nbsp;Syed S Ali","doi":"10.4103/abr.abr_306_21","DOIUrl":"https://doi.org/10.4103/abr.abr_306_21","url":null,"abstract":"<p><strong>Background: </strong><i>Rosmarinus officinalis</i> (rosemary) is a common household plant with needle-like leaves and white flowers that belongs to the family Lamiaceae and has various medicinal properties including ailments of hair and scalp, cardiovascular, nervous disorders, etc., In the current work, we have focused on formulation and evaluation of 1% hair lotion incorporated with methanolic extract of <i>R. officinalis</i>.</p><p><strong>Materials and methods: </strong>The aerial parts of the plant were extracted with methanol and then the nature of phytochemicals were identified by chemical tests. It showed the presence of proteins, amino acids, fats and oils, steroids, glycosides, phenolic compounds, flavonoids, volatile oil, and vitamins. The extract was formulated to a suitable hair lotion and then evaluated for its various quality control parameters. Finally, the lotion was evaluated for hair growth promoting activity on C57BL/6 mice, using water as control and 2% minoxidil hair lotion as standard.</p><p><strong>Results: </strong>It was observed that the formulated 1% herbal hair lotion passed all the evaluation parameters and showed a significant hair growth promoting activity than the standard drug-treated animals.</p><p><strong>Conclusion: </strong>Although several researches have been carried out on the rosemary, an investigation on formulation of hair lotion adding the extract of the aerial part of the plant is for the first time. Since our formulation exhibited an excellent activity, it can be well thought out to be an alternative to the commercially available hair growth promoters with a lot of unwanted effects.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"60"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/19/6a/ABR-12-60.PMC10186041.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9861850","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Are ROMA and HE4 More Accurate than CA-125, in Predicting of Ovarian Epithelial Carcinoma? 预测卵巢上皮癌,ROMA和HE4比CA-125更准确吗?
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_264_22
Fariba Behnamfar, Aazam Zafarbakhsh, Narges Ahmadian

Background: Evaluation of ovarian tumors based on tumor markers could have high clinical importance. In this study, we aimed to assess the predictive value of HE4 and Risk of Ovarian Malignancy Algorithm (ROMA) compared to CA-125 in the Malignancy of ovarian epithelial masses.

Materials and methods: This cross-sectional study was performed in 2020-2021 including 203 patients. Serum HE4 and CA-125 levels were checked before surgery. According to the pathology report (benign, borderline, or malignant epithelial mass), the predictive values of the three markers were evaluated.

Results: About 146 cases were benign; 14 cases were borderline and 43 cases were malignant. Most patients (69.8%) in the malignant group were in stage 3. Significantly higher levels of all three markers (CA-125, HE4, and ROMA) were found in patients with malignant tumors compared to benign or borderline tumors (P < 0.001 for all). The sensitivity of CA-125 was the highest (90.7%) in pre- and post-menopausal patients but the specificity of HE4 and ROMA were higher than CA-125 (98.1% and 97.5%, respectively, versus 86.9% for CA-125). In post-menopausal patients, both sensitivities of HE4 and ROMA were 90.5% and the specificity and sensitivity of CA-125 were the highest (95.2% and 100%). In premenopausal patients, the sensitivity of ROMA (90.9%) and the specificity of HE4 (100%) were the highest.

Conclusions: HE4 and ROMA are not necessary for postmenopausal patients in low-resource areas and a check of serum CA-125 will be enough. The higher-cost, ROMA, and HE4 checks are recommended in premenopausal people because they are more sensitive.

背景:基于肿瘤标志物评价卵巢肿瘤具有重要的临床意义。在这项研究中,我们旨在评估HE4和卵巢恶性肿瘤风险算法(ROMA)与CA-125在卵巢上皮肿块恶性肿瘤中的预测价值。材料和方法:本横断面研究于2020-2021年进行,包括203例患者。术前检查血清HE4和CA-125水平。根据病理报告(良性、交界性或恶性上皮肿块),评估三种标志物的预测价值。结果:146例为良性;交界性14例,恶性43例。恶性组以3期患者居多(69.8%)。与良性肿瘤或交界性肿瘤相比,恶性肿瘤患者的所有三种标志物(CA-125、HE4和ROMA)水平均显著升高(P < 0.001)。CA-125的敏感性在绝经前和绝经后患者中最高(90.7%),但HE4和ROMA的特异性高于CA-125(分别为98.1%和97.5%,而CA-125为86.9%)。绝经后患者HE4和ROMA的敏感性均为90.5%,CA-125的特异性和敏感性最高(95.2%和100%)。在绝经前患者中,ROMA的敏感性(90.9%)和HE4的特异性(100%)最高。结论:低资源地区绝经后患者不需要检测HE4和ROMA,检查血清CA-125即可。建议绝经前人群进行成本较高的ROMA和HE4检查,因为它们更敏感。
{"title":"Are ROMA and HE4 More Accurate than CA-125, in Predicting of Ovarian Epithelial Carcinoma?","authors":"Fariba Behnamfar,&nbsp;Aazam Zafarbakhsh,&nbsp;Narges Ahmadian","doi":"10.4103/abr.abr_264_22","DOIUrl":"https://doi.org/10.4103/abr.abr_264_22","url":null,"abstract":"<p><strong>Background: </strong>Evaluation of ovarian tumors based on tumor markers could have high clinical importance. In this study, we aimed to assess the predictive value of HE4 and Risk of Ovarian Malignancy Algorithm (ROMA) compared to CA-125 in the Malignancy of ovarian epithelial masses.</p><p><strong>Materials and methods: </strong>This cross-sectional study was performed in 2020-2021 including 203 patients. Serum HE4 and CA-125 levels were checked before surgery. According to the pathology report (benign, borderline, or malignant epithelial mass), the predictive values of the three markers were evaluated.</p><p><strong>Results: </strong>About 146 cases were benign; 14 cases were borderline and 43 cases were malignant. Most patients (69.8%) in the malignant group were in stage 3. Significantly higher levels of all three markers (CA-125, HE4, and ROMA) were found in patients with malignant tumors compared to benign or borderline tumors (<i>P</i> < 0.001 for all). The sensitivity of CA-125 was the highest (90.7%) in pre- and post-menopausal patients but the specificity of HE4 and ROMA were higher than CA-125 (98.1% and 97.5%, respectively, versus 86.9% for CA-125). In post-menopausal patients, both sensitivities of HE4 and ROMA were 90.5% and the specificity and sensitivity of CA-125 were the highest (95.2% and 100%). In premenopausal patients, the sensitivity of ROMA (90.9%) and the specificity of HE4 (100%) were the highest.</p><p><strong>Conclusions: </strong>HE4 and ROMA are not necessary for postmenopausal patients in low-resource areas and a check of serum CA-125 will be enough. The higher-cost, ROMA, and HE4 checks are recommended in premenopausal people because they are more sensitive.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"156"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2a/a0/ABR-12-156.PMC10410412.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9976181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biotinidase Deficiency in the Second Decade with Atypical Neuroimaging Findings. 第二十年生物素酶缺乏伴非典型神经影像学表现。
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_98_22
Vykuntaraju K Gowda, Amit Avaragollapuravarga Mathada, Varunvenkat M Srinivasan, Dhananjaya K Vamyanmane

Biotinidase deficiency is a rare autosomal recessive neurometabolic disorder resulting in biotin deficiency. Our patient presented with seizures and developmental delay since infancy and was started on megavitamin supplements. At 14 years, she presented with motor regression with encephalopathy after discontinuation of vitamins. There were no skin and hair changes. Magnetic resonance imaging (MRI) of the brain showed bilateral symmetrical posterior putamen signal changes. Tandem mass spectroscopy showed increased methyl malonyl carnitine and 3-OH isovaleryl carnitine. There was a low biotinidase level, and a pathogenic variant in the BTD gene in the next-generation sequencing was identified. Special importance is placed on the unusual symmetric posterior putamen involvement seen in MRI of the brain.

生物素酶缺乏症是一种罕见的常染色体隐性神经代谢疾病,导致生物素缺乏。我们的病人表现出癫痫发作和发育迟缓,从婴儿期开始服用维生素补充剂。14岁时,她在停用维生素后出现运动退化和脑病。皮肤和头发都没有变化。脑磁共振成像(MRI)显示双侧对称后壳核信号改变。串联质谱分析显示甲基丙二酰肉毒碱和3-OH异戊酰肉毒碱增加。生物素酶水平低,在下一代测序中鉴定出BTD基因的致病性变异。特别重要的是在MRI上看到的不寻常的对称后壳核受累。
{"title":"Biotinidase Deficiency in the Second Decade with Atypical Neuroimaging Findings.","authors":"Vykuntaraju K Gowda,&nbsp;Amit Avaragollapuravarga Mathada,&nbsp;Varunvenkat M Srinivasan,&nbsp;Dhananjaya K Vamyanmane","doi":"10.4103/abr.abr_98_22","DOIUrl":"https://doi.org/10.4103/abr.abr_98_22","url":null,"abstract":"<p><p>Biotinidase deficiency is a rare autosomal recessive neurometabolic disorder resulting in biotin deficiency. Our patient presented with seizures and developmental delay since infancy and was started on megavitamin supplements. At 14 years, she presented with motor regression with encephalopathy after discontinuation of vitamins. There were no skin and hair changes. Magnetic resonance imaging (MRI) of the brain showed bilateral symmetrical posterior putamen signal changes. Tandem mass spectroscopy showed increased methyl malonyl carnitine and 3-OH isovaleryl carnitine. There was a low biotinidase level, and a pathogenic variant in the <i>BTD</i> gene in the next-generation sequencing was identified. Special importance is placed on the unusual symmetric posterior putamen involvement seen in MRI of the brain.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"148"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/d4/ABR-12-148.PMC10410414.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9978961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Effect and Safety of Olanzapine on Nausea and Vomiting in Children Receiving Moderately Emetogenic Chemotherapy. 奥氮平治疗中度致吐性化疗儿童恶心呕吐的疗效和安全性。
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_356_22
Aziz Eghbali, Tahereh Bagherloo, Ali Ghasemi, Roghayeh R Afzal, Aygin Eghbali, Kazem Ghaffari

Background: In order to improve the complete recovery of nausea and vomiting, we conducted a study with the aim of preventing acute and delayed nausea and vomiting in children undergoing moderate emetogenic chemotherapy.

Materials and methods: A clinical trial study was done on 130 children received chemotherapy. Patients received olanzapine and placebo. All groups received granisetron along with dexamethasone (DEX). The severity of chemotherapy-induced nausea and vomiting (CINV) induced by chemotherapy was compared in two groups.

Results: The severity of nausea on the first, second, third, and fourth days was not significantly different (P > .05) in two groups. The number of patients without vomiting was significantly different during the first 24 hours after chemotherapy between patients in the two groups (82.3% vs 64.5%; P = .016).

Conclusion: This study showed that olanzapine, which acts as an inhibitor of neurotransmitters, had a favorable efficacy in controlling acute and delayed CINV. More studies with large sample size are needed to compare the effect of olanzapine with other agents including aprepitant and palonosetron in the prevention of CINV.

背景:为了提高恶心呕吐的完全恢复,我们进行了一项旨在预防中度致吐性化疗儿童急性和延迟性恶心呕吐的研究。材料与方法:对130例接受化疗的儿童进行临床试验研究。患者接受奥氮平和安慰剂治疗。各组均给予格拉司琼联合地塞米松治疗。比较两组患者化疗引起的恶心呕吐(CINV)严重程度。结果:两组患者第1、2、3、4天恶心程度差异无统计学意义(P > 0.05)。两组患者化疗后前24小时无呕吐的患者数量差异有统计学意义(82.3% vs 64.5%;P = .016)。结论:本研究表明奥氮平作为神经递质抑制剂对急性和迟发性CINV有良好的控制作用。奥氮平与阿瑞吡坦、帕洛诺司琼等其他药物预防CINV的效果需要更多大样本量的研究来比较。
{"title":"The Effect and Safety of Olanzapine on Nausea and Vomiting in Children Receiving Moderately Emetogenic Chemotherapy.","authors":"Aziz Eghbali,&nbsp;Tahereh Bagherloo,&nbsp;Ali Ghasemi,&nbsp;Roghayeh R Afzal,&nbsp;Aygin Eghbali,&nbsp;Kazem Ghaffari","doi":"10.4103/abr.abr_356_22","DOIUrl":"https://doi.org/10.4103/abr.abr_356_22","url":null,"abstract":"<p><strong>Background: </strong>In order to improve the complete recovery of nausea and vomiting, we conducted a study with the aim of preventing acute and delayed nausea and vomiting in children undergoing moderate emetogenic chemotherapy.</p><p><strong>Materials and methods: </strong>A clinical trial study was done on 130 children received chemotherapy. Patients received olanzapine and placebo. All groups received granisetron along with dexamethasone (DEX). The severity of chemotherapy-induced nausea and vomiting (CINV) induced by chemotherapy was compared in two groups.</p><p><strong>Results: </strong>The severity of nausea on the first, second, third, and fourth days was not significantly different (<i>P</i> > .05) in two groups. The number of patients without vomiting was significantly different during the first 24 hours after chemotherapy between patients in the two groups (82.3% vs 64.5%; <i>P</i> = .016).</p><p><strong>Conclusion: </strong>This study showed that olanzapine, which acts as an inhibitor of neurotransmitters, had a favorable efficacy in controlling acute and delayed CINV. More studies with large sample size are needed to compare the effect of olanzapine with other agents including aprepitant and palonosetron in the prevention of CINV.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"158"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/a4/ed/ABR-12-158.PMC10410408.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low Current Intensity Plus an Ineffective Dose of Morphine Affect Conditioning Place Preference Through Different Pathways in the Lateral Habenula. 低电流强度加无效剂量吗啡通过外侧缰的不同通路影响条件反射位置偏好。
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_126_22
Elahe Amohashemi, Parham Reisi, Hojjat Allah Alaei

Background: The involvement of lateral habenula and the ineffective dose of morphine on reward-related learning and memory is less well-known. This study looked into the effects of electrical stimulation, GABAB receptor blockade, and a combination of both with morphine on conditioned place preference.

Materials and methods: In this experiment, male rats were anesthetized with ketamine/xylazine (six rats in each group). A 5-day biased conditioned place preference paradigm was used for the behavioral test. The effects of electrical stimulation and phaclofen plus a low dose of morphine on the acquisition and expression phases were examined during conditioning sessions and before the test phase, respectively.

Results: The conditioning scores were reduced by antagonist injection during the acquisition phase. Interestingly, different intensities exhibited opposite effects on the acquisition phase. Conditioned place preference scores during the acquisition phase were significantly induced by 25 μA electrical stimulation, while conditioning scores were suppressed by electrical stimulation at 150 μA. Phaclofen (2 μg/rat) combined with high intensity induced aversion during the acquisition phase, while inhibiting expression. In contrast, high intensity with phaclofen (1 μg/rat) inhibited only the acquisition session. However, low intensity during the acquisition phase had an additive effect that was prevented by pretreatment with phaclofen (2 μg/rat), but this response was modified by the antagonist's low dose.

Conclusions: A behavioral technique called conditioned place preference is frequently used to evaluate learning that is related to rewards. Therefore, lateral habenula electrical stimulation and phaclofen plus morphine could affect place preference through the involvement of the reward system.

背景:外侧链的受累和吗啡剂量对奖励相关学习记忆的无效作用尚不清楚。本研究探讨了电刺激、GABAB受体阻断以及两者联合吗啡对条件位置偏好的影响。材料与方法:本实验采用氯胺酮/噻嗪麻醉雄性大鼠,每组6只。行为测试采用5天有偏条件位置偏好范式。在条件反射阶段和测试阶段前分别观察电刺激和苯氯芬加低剂量吗啡对大鼠习得期和表达期的影响。结果:在获得期注射拮抗剂可降低条件反射评分。有趣的是,不同的强度在习得阶段表现出相反的效果。25 μA电刺激显著诱导习得期条件位置偏好得分,而150 μA电刺激抑制习得期条件偏好得分。苯氯芬(2 μg/大鼠)在获得期联合高强度诱导厌恶,同时抑制表达。相比之下,高剂量苯氯芬(1 μg/大鼠)仅抑制习得期。然而,在获取期的低剂量有一种加性效应,用苯氯芬(2 μg/大鼠)预处理可以阻止这种效应,但这种效应被低剂量拮抗剂修饰。结论:一种被称为条件位置偏好的行为技术经常被用来评估与奖励相关的学习。因此,侧缰核电刺激和苯氯芬加吗啡可以通过奖赏系统的参与影响位置偏好。
{"title":"Low Current Intensity Plus an Ineffective Dose of Morphine Affect Conditioning Place Preference Through Different Pathways in the Lateral Habenula.","authors":"Elahe Amohashemi,&nbsp;Parham Reisi,&nbsp;Hojjat Allah Alaei","doi":"10.4103/abr.abr_126_22","DOIUrl":"https://doi.org/10.4103/abr.abr_126_22","url":null,"abstract":"<p><strong>Background: </strong>The involvement of lateral habenula and the ineffective dose of morphine on reward-related learning and memory is less well-known. This study looked into the effects of electrical stimulation, GABA<sub>B</sub> receptor blockade, and a combination of both with morphine on conditioned place preference.</p><p><strong>Materials and methods: </strong>In this experiment, male rats were anesthetized with ketamine/xylazine (six rats in each group). A 5-day biased conditioned place preference paradigm was used for the behavioral test. The effects of electrical stimulation and phaclofen plus a low dose of morphine on the acquisition and expression phases were examined during conditioning sessions and before the test phase, respectively.</p><p><strong>Results: </strong>The conditioning scores were reduced by antagonist injection during the acquisition phase. Interestingly, different intensities exhibited opposite effects on the acquisition phase. Conditioned place preference scores during the acquisition phase were significantly induced by 25 μA electrical stimulation, while conditioning scores were suppressed by electrical stimulation at 150 μA. Phaclofen (2 μg/rat) combined with high intensity induced aversion during the acquisition phase, while inhibiting expression. In contrast, high intensity with phaclofen (1 μg/rat) inhibited only the acquisition session. However, low intensity during the acquisition phase had an additive effect that was prevented by pretreatment with phaclofen (2 μg/rat), but this response was modified by the antagonist's low dose.</p><p><strong>Conclusions: </strong>A behavioral technique called conditioned place preference is frequently used to evaluate learning that is related to rewards. Therefore, lateral habenula electrical stimulation and phaclofen plus morphine could affect place preference through the involvement of the reward system.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"161"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2f/ee/ABR-12-161.PMC10410425.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9981624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of Teriparatide on Clinical and Radiologic Long-Term Outcomes after Fixation of Pertrochanteric Hip Fractures. 特立帕肽对髋大转子骨折固定后临床和影像学长期预后的影响。
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_127_22
Mehdi Hosseini Khameneh, Mona Gorji, Meisam Jafari Kafi-Ababdi, Farsad Biglari, Morteza Gholipour, Keivan Asadi, Amir Sabbaghzadeh

Background: Pertrochanteric hip fractures are common and among serious injuries of the old population with considerable mortality and morbidity. The aim of this study was to evaluate long-term effects of recombinant human parathyroid hormone on postoperative clinical and radiologic outcomes in elderly patients with pertrochanteric hip fractures.

Materials and methods: Between 2016 and 2019, we prospectively assessed 80 patients with pertrochanteric hip fractures who underwent reduction and internal fixation with a dynamic hip screw. Patients were divided randomly into two groups. About 40 patients in the control group who received supplementary calcium (1000 mg/day) and vitamin D (800 UI/day), and 40 others who were treated additionally with 20-28 mg daily teriparatide for three months post-operatively. The functional and radiologic assessment was done using visual analog scale (VAS), Harris hip score (HSS), and standard radiographs of the hip.

Results: At the final follow-up, there was a significant difference between the two groups regarding average HSS (68.38 in the control group versus 74.12 in the treatment group, P-value <0.001). VAS score was also significantly lower in the treatment group (P-value <0.001). Regarding radiographic evidence of union, the results were not statistically different between the two groups.

Conclusions: The current study illustrated that short-term daily administration of teriparatide improves long-term functional outcome after pertrochanteric hip fracture fixation and can reduce the pain but does not affect union and callus formation.

背景:股骨粗隆部骨折是老年人群中常见的严重损伤,具有相当高的死亡率和发病率。本研究的目的是评估重组人甲状旁腺激素对老年股骨粗隆骨折患者术后临床和影像学预后的长期影响。材料和方法:在2016年至2019年期间,我们前瞻性评估了80例髋粗隆骨折患者,这些患者接受了动态髋螺钉复位和内固定。患者随机分为两组。对照组约40例患者接受补钙(1000 mg/天)和维生素D (800 UI/天)治疗,另外40例患者在术后3个月额外治疗特立帕肽20 ~ 28 mg/天。使用视觉模拟量表(VAS)、Harris髋关节评分(HSS)和髋关节标准x线片进行功能和放射学评估。结果:在最后随访时,两组患者的平均HSS有显著差异(对照组68.38,治疗组74.12,p值p值)。结论:目前的研究表明,每日短期服用特立帕肽可改善股骨粗隆骨折固定后的长期功能结局,减轻疼痛,但不影响愈合和骨痂形成。
{"title":"Effects of Teriparatide on Clinical and Radiologic Long-Term Outcomes after Fixation of Pertrochanteric Hip Fractures.","authors":"Mehdi Hosseini Khameneh,&nbsp;Mona Gorji,&nbsp;Meisam Jafari Kafi-Ababdi,&nbsp;Farsad Biglari,&nbsp;Morteza Gholipour,&nbsp;Keivan Asadi,&nbsp;Amir Sabbaghzadeh","doi":"10.4103/abr.abr_127_22","DOIUrl":"https://doi.org/10.4103/abr.abr_127_22","url":null,"abstract":"<p><strong>Background: </strong>Pertrochanteric hip fractures are common and among serious injuries of the old population with considerable mortality and morbidity. The aim of this study was to evaluate long-term effects of recombinant human parathyroid hormone on postoperative clinical and radiologic outcomes in elderly patients with pertrochanteric hip fractures.</p><p><strong>Materials and methods: </strong>Between 2016 and 2019, we prospectively assessed 80 patients with pertrochanteric hip fractures who underwent reduction and internal fixation with a dynamic hip screw. Patients were divided randomly into two groups. About 40 patients in the control group who received supplementary calcium (1000 mg/day) and vitamin D (800 UI/day), and 40 others who were treated additionally with 20-28 mg daily teriparatide for three months post-operatively. The functional and radiologic assessment was done using visual analog scale (VAS), Harris hip score (HSS), and standard radiographs of the hip.</p><p><strong>Results: </strong>At the final follow-up, there was a significant difference between the two groups regarding average HSS (68.38 in the control group versus 74.12 in the treatment group, <i>P</i>-value <0.001). VAS score was also significantly lower in the treatment group (<i>P</i>-value <0.001). Regarding radiographic evidence of union, the results were not statistically different between the two groups.</p><p><strong>Conclusions: </strong>The current study illustrated that short-term daily administration of teriparatide improves long-term functional outcome after pertrochanteric hip fracture fixation and can reduce the pain but does not affect union and callus formation.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"139"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/aa/ABR-12-139.PMC10331546.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9869906","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Missense Mutation in the TGF-β-binding Protein-Like Domain 3 of FBN1 Causes Weill-Marchesani Syndrome with Intellectual Disability. FBN1中TGF-β结合蛋白样结构域3的新错义突变导致wel - marchesani综合征伴智力残疾
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_138_22
Mahdieh Hassani, Sara Taghizadeh, Anahita Farahzad Broujeni, Mahvash Habibi, Setareh Banitalebi, Mahbubeh Kasiri, Alireza Sadeghi, Ahoura Nozari

Background: Weill-Marchesani syndrome (WMS) is a rare connective tissue disorder characterized by locus heterogeneity and variable expressivity. Patients suffering from WMS are described by short stature, brachydactyly, joint stiffness, congenital heart defects, and eye abnormalities. This disorder is inherited in two different modes; the autosomal dominant form of the disease occurs due to a mutation in FBN1, and the recessive form results from mutations in ADAMTS10, ADAMTS17, or LTP2 genes.

Materials and methods: The family recruited in this study was a consanguineous Iranian family with an intellectually disabled girl referred to the Sadra Genetics laboratory, Shahrekord, Iran. The clinical history of family members was investigated. Whole-Exome Sequencing (WES) for the proband was performed. Sanger sequencing was used to assess the segregation of candidate variants in the other family members.

Results: Whole-exome sequencing analysis revealed a novel heterozygote mutation in the proband located at the third TGF-β-binding protein-like (TB) domain of the FBN1 gene (NM000138: c.2066A>G: (p. Glu689Gly), NP_000129.3, in exon 17 of the gene). Co-segregation analysis with Sanger sequencing confirmed this mutation in the affected members of the pedigree.

Conclusion: Our findings represent an autosomal dominant form of specific WMS resulting from a substitution mutation in the FBN1 gene. In addition to the typical manifestations of the disorder, mild intellectual disability (ID) was identified in the 8-year-old proband. Given the fact that ID is primarily reported in ADAMTS10 mutated cases, this family was clinically and genetically a novel case.

背景:Weill-Marchesani综合征(WMS)是一种罕见的结缔组织疾病,其特点是基因座异质性和表达性可变。WMS患者表现为身材矮小、指短、关节僵硬、先天性心脏缺陷和眼睛异常。这种疾病以两种不同的方式遗传;该病的常染色体显性形式是由FBN1突变引起的,而隐性形式是由ADAMTS10、ADAMTS17或LTP2基因突变引起的。材料和方法:本研究招募的家庭是一个近亲伊朗家庭,有一个智力残疾的女孩被转介到伊朗Shahrekord的Sadra遗传学实验室。调查家族成员的临床病史。先证者进行全外显子组测序(WES)。Sanger测序用于评估候选变异在其他家庭成员中的分离。结果:全外显子组测序分析显示,在FBN1基因第3个TGF-β结合蛋白样(TB)结构域(NM000138: c.2066A>G: (p. Glu689Gly), NP_000129.3,基因外显子17)的先证者中发现了一个新的杂合子突变。共分离分析与桑格测序证实了这种突变在系谱的影响成员。结论:我们的研究结果代表了一种常染色体显性形式的特异性WMS,由FBN1基因的替代突变引起。除了该障碍的典型表现外,在8岁的先证者中发现了轻度智力残疾(ID)。鉴于ID主要在ADAMTS10突变病例中报道,该家族在临床上和遗传学上都是一个新病例。
{"title":"A Novel Missense Mutation in the TGF-β-binding Protein-Like Domain 3 of <i>FBN1</i> Causes Weill-Marchesani Syndrome with Intellectual Disability.","authors":"Mahdieh Hassani,&nbsp;Sara Taghizadeh,&nbsp;Anahita Farahzad Broujeni,&nbsp;Mahvash Habibi,&nbsp;Setareh Banitalebi,&nbsp;Mahbubeh Kasiri,&nbsp;Alireza Sadeghi,&nbsp;Ahoura Nozari","doi":"10.4103/abr.abr_138_22","DOIUrl":"https://doi.org/10.4103/abr.abr_138_22","url":null,"abstract":"<p><strong>Background: </strong>Weill-Marchesani syndrome (WMS) is a rare connective tissue disorder characterized by locus heterogeneity and variable expressivity. Patients suffering from WMS are described by short stature, brachydactyly, joint stiffness, congenital heart defects, and eye abnormalities. This disorder is inherited in two different modes; the autosomal dominant form of the disease occurs due to a mutation in <i>FBN1</i>, and the recessive form results from mutations in <i>ADAMTS10</i>, <i>ADAMTS17</i>, or <i>LTP2</i> genes.</p><p><strong>Materials and methods: </strong>The family recruited in this study was a consanguineous Iranian family with an intellectually disabled girl referred to the Sadra Genetics laboratory, Shahrekord, Iran. The clinical history of family members was investigated. Whole-Exome Sequencing (WES) for the proband was performed. Sanger sequencing was used to assess the segregation of candidate variants in the other family members.</p><p><strong>Results: </strong>Whole-exome sequencing analysis revealed a novel heterozygote mutation in the proband located at the third TGF-β-binding protein-like (TB) domain of the <i>FBN1 g</i>ene (NM000138: c.2066A>G: (p. Glu689Gly), NP_000129.3, in exon 17 of the gene). Co-segregation analysis with Sanger sequencing confirmed this mutation in the affected members of the pedigree.</p><p><strong>Conclusion: </strong>Our findings represent an autosomal dominant form of specific WMS resulting from a substitution mutation in the <i>FBN1 g</i>ene. In addition to the typical manifestations of the disorder, mild intellectual disability (ID) was identified in the 8-year-old proband. Given the fact that ID is primarily reported in <i>ADAMTS10</i> mutated cases, this family was clinically and genetically a novel case.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"114"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8b/cd/ABR-12-114.PMC10241635.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9590963","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Feasibility Study and Design of Registration System for Upper Gastrointestinal Bleeding Patients in Isfahan Province. 伊斯法罕省上消化道出血患者登记系统的可行性研究与设计。
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_230_21
Maryam Soheilipour, Mehdi Kazemi, Behjat Taheri, Peyman Adibi, Ibrahim Abdollahpour

Background: Disease registration is an organized system for collecting, storing, retrieving, analyzing a particular disease or exposure to known substances in a specific population. The aim of this study was to assess the feasibility and design of the registration system for upper gastrointestinal bleeding patients based on patients referring to Al-Zahra and Khorshid hospitals, Isfahan, Iran.

Materials and methods: This study is a research action study in which the members of the registration system team are hospital triage physicians, internal residents in the Emergency department of hospital, subspecialty assistants and gastroenterologists, statisticians (epidemiologists and methodologists), and two trained persons were specified to collect medical information and documents. The data collection tool is a researcher-made checklist. Based on the available tools, the most important criteria related to gastrointestinal bleeding were selected. In the next step, the criteria selected in the council, including team members, were reviewed and a preliminary draft was prepared to record the information of patients.

Results: The results indicated the final version of the checklist in three parts including demographic variables (age, sex, education, et al.), main variables (as the minimum data required by a person to register in the checklist (patient's clinical signs)), extended main variables (its information is designed to be used to diagnose, treat, and follow-up the patient in later stages).

Conclusion: It seems to be predictable by establishing a system for recording gastrointestinal bleeding diseases, disease prevalence, monitoring services and treatment of patients, survival analysis and evaluation of clinical care outcomes, finding patients at higher risk for emergency treatment, reviewing drug interventions, and interventional activities.

背景:疾病登记是一种有组织的系统,用于收集、储存、检索、分析特定人群中的特定疾病或暴露于已知物质。本研究以伊朗伊斯法罕Al-Zahra和Khorshid医院的患者为研究对象,评估上消化道出血患者登记系统的可行性和设计。材料与方法:本研究为研究性行动研究,注册系统团队成员为医院分诊医师、医院急诊科住院医师、亚专科助理和胃肠科医师、统计学家(流行病学家和方法学家),并指定两名经过培训的人员收集医疗信息和文件。数据收集工具是研究人员制作的清单。根据可用的工具,选择与胃肠道出血相关的最重要的标准。下一步,对委员会选定的标准进行审查,包括小组成员,并准备了一份初步草案,以记录患者的信息。结果:统计变量(年龄、性别、教育程度等)、主要变量(作为登记人员在检查表中所需的最小数据(患者的临床体征))、扩展主要变量(其信息旨在用于患者的诊断、治疗和后期随访)三部分组成了最终版本的检查表。结论:通过建立胃肠出血疾病记录、疾病流行情况、患者监测服务和治疗、生存分析和临床护理结果评价、发现高危患者进行急诊治疗、回顾药物干预和干预活动等系统,似乎可以预测胃肠出血的发生。
{"title":"Feasibility Study and Design of Registration System for Upper Gastrointestinal Bleeding Patients in Isfahan Province.","authors":"Maryam Soheilipour,&nbsp;Mehdi Kazemi,&nbsp;Behjat Taheri,&nbsp;Peyman Adibi,&nbsp;Ibrahim Abdollahpour","doi":"10.4103/abr.abr_230_21","DOIUrl":"https://doi.org/10.4103/abr.abr_230_21","url":null,"abstract":"<p><strong>Background: </strong>Disease registration is an organized system for collecting, storing, retrieving, analyzing a particular disease or exposure to known substances in a specific population. The aim of this study was to assess the feasibility and design of the registration system for upper gastrointestinal bleeding patients based on patients referring to Al-Zahra and Khorshid hospitals, Isfahan, Iran.</p><p><strong>Materials and methods: </strong>This study is a research action study in which the members of the registration system team are hospital triage physicians, internal residents in the Emergency department of hospital, subspecialty assistants and gastroenterologists, statisticians (epidemiologists and methodologists), and two trained persons were specified to collect medical information and documents. The data collection tool is a researcher-made checklist. Based on the available tools, the most important criteria related to gastrointestinal bleeding were selected. In the next step, the criteria selected in the council, including team members, were reviewed and a preliminary draft was prepared to record the information of patients.</p><p><strong>Results: </strong>The results indicated the final version of the checklist in three parts including demographic variables (age, sex, education, <i>et al</i>.), main variables (as the minimum data required by a person to register in the checklist (patient's clinical signs)), extended main variables (its information is designed to be used to diagnose, treat, and follow-up the patient in later stages).</p><p><strong>Conclusion: </strong>It seems to be predictable by establishing a system for recording gastrointestinal bleeding diseases, disease prevalence, monitoring services and treatment of patients, survival analysis and evaluation of clinical care outcomes, finding patients at higher risk for emergency treatment, reviewing drug interventions, and interventional activities.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"115"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/5d/ABR-12-115.PMC10241624.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9590965","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Cutaneous Leishmaniasis with Intense Pulsed Light: Is it Effective? 强脉冲光治疗皮肤利什曼病有效吗?
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_410_21
Amirhossein Siadat, Hamid Galehdari, Zabiholah Shahmoradi, Fariba Iraji, Azadeh Zolfaghari, Nazli Ansari

Background: Cutaneous leishmaniasis (CL) is a common parasitic disorder that is endemic in many countries. There is no completely effective treatment for this condition, but pentavalent antimony compounds are regarded as the main treatment. Different laser types have been used for treatment of CL with variable success but to our best knowledge, there is no published paper regarding use of intense pulsed light (IPL) for treatment of CL.

Materials and methods: In this randomized, single-blind clinical trial study, we compared the efficacy of intralesional glucantime alone versus intralesional glucantime plus weekly IPL for treatment of 54 patients with confirmed cutaneous leishmaniasis for a maximum of eight weeks as a randomized, clinical trial.

Results: Although it was not statistically significant, combination treatment was more effective than intralesional glucantime alone (P > 0.05). However, the velocity of healing was significantly higher in the IPL plus intralesional glucantime alone versus glucantime alone. No side effect was observed in both groups.

Discussion: To better evaluate the efficacy of IPL, more studies with a higher number of patients and using various IPL filters are recommended.

背景:皮肤利什曼病是一种常见的寄生虫病,在许多国家流行。目前还没有完全有效的治疗方法,但五价锑化合物被认为是主要的治疗方法。不同类型的激光已用于治疗CL的不同的成功,但据我们所知,没有发表的论文关于使用强脉冲光(IPL)治疗CL。材料和方法:在这项随机、单盲临床试验研究中,我们比较了局部注射葡聚糖酶与局部注射葡聚糖酶加每周IPL治疗54例确诊皮肤利什曼病的疗效,为期最多8周。结果:联合治疗虽无统计学意义,但明显优于单药治疗(P > 0.05)。然而,IPL联合局部内葡聚糖治疗的愈合速度明显高于单纯葡聚糖治疗。两组均未见副作用。讨论:为了更好地评估IPL的疗效,建议更多的患者和使用不同的IPL滤镜进行更多的研究。
{"title":"Treatment of Cutaneous Leishmaniasis with Intense Pulsed Light: Is it Effective?","authors":"Amirhossein Siadat,&nbsp;Hamid Galehdari,&nbsp;Zabiholah Shahmoradi,&nbsp;Fariba Iraji,&nbsp;Azadeh Zolfaghari,&nbsp;Nazli Ansari","doi":"10.4103/abr.abr_410_21","DOIUrl":"https://doi.org/10.4103/abr.abr_410_21","url":null,"abstract":"<p><strong>Background: </strong>Cutaneous leishmaniasis (CL) is a common parasitic disorder that is endemic in many countries. There is no completely effective treatment for this condition, but pentavalent antimony compounds are regarded as the main treatment. Different laser types have been used for treatment of CL with variable success but to our best knowledge, there is no published paper regarding use of intense pulsed light (IPL) for treatment of CL.</p><p><strong>Materials and methods: </strong>In this randomized, single-blind clinical trial study, we compared the efficacy of intralesional glucantime alone versus intralesional glucantime plus weekly IPL for treatment of 54 patients with confirmed cutaneous leishmaniasis for a maximum of eight weeks as a randomized, clinical trial.</p><p><strong>Results: </strong>Although it was not statistically significant, combination treatment was more effective than intralesional glucantime alone (<i>P</i> > 0.05). However, the velocity of healing was significantly higher in the IPL plus intralesional glucantime alone versus glucantime alone. No side effect was observed in both groups.</p><p><strong>Discussion: </strong>To better evaluate the efficacy of IPL, more studies with a higher number of patients and using various IPL filters are recommended.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"125"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/9c/d6/ABR-12-125.PMC10331534.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10172600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Oral Prednisolone on Pain after Tonsillectomy with Sutures: A Randomized Clinical Trial. 口服强的松龙对缝合扁桃体切除术后疼痛的影响:一项随机临床试验。
Pub Date : 2023-01-01 DOI: 10.4103/abr.abr_410_22
Amin Shayan, Nezammedin Berjis, Sayed Mostafa Hashemi

Background: Tonsillectomy, one of the most common otolaryngology surgeries, often results in postoperative complications such as pain and bleeding. Currently, there is no consensus on postoperative pain management. This study aimed to determine the efficacy of oral prednisolone on postoperative pain after tonsillectomy with sutures.

Materials and methods: This pilot, double-blind, randomized clinical trial was conducted at two tertiary care centers affiliated with Isfahan University of Medical Sciences. Patients who underwent tonsillectomy with sutures were included. Participants were randomly divided into experimental and control groups. In the experimental group, patients received oral prednisolone in addition to acetaminophen; in the control group, patients received acetaminophen and a placebo. Post-operative pain was evaluated by a visual analog scale daily for ten days.

Results: Initially, 60 patients were enrolled in the study; however, four were excluded due to non-attendance at follow-up visits. The groups were similar in terms of age and sex (both P values >0.05). In the study, postoperative pain from 1st day to the 10th day was lower in the experimental group than in the control group (P value <0.05).

Conclusion: Numerous studies have been conducted on the effect of intravenous corticosteroids on this pain. However, there is no consensus on the analgesic role of oral corticosteroids for post-tonsillectomy pain. The present study showed that oral prednisolone is effective on post-operative pain compared to a placebo.

背景:扁桃体切除术是耳鼻喉科最常见的手术之一,术后常出现疼痛和出血等并发症。目前,对于术后疼痛的处理尚无共识。本研究旨在确定口服强的松龙对缝合扁桃体切除术后疼痛的疗效。材料和方法:本试点双盲随机临床试验在伊斯法罕医科大学附属的两个三级保健中心进行。包括接受扁桃体切除并缝合的患者。参与者被随机分为实验组和对照组。实验组患者在对乙酰氨基酚的基础上口服强的松龙;在对照组中,患者服用对乙酰氨基酚和安慰剂。术后疼痛以视觉模拟量表评估,每天10天。结果:最初,60名患者入组研究;然而,有4人因未参加随访而被排除在外。各组年龄、性别相近(P值均>0.05)。在本研究中,实验组术后第1天至第10天的疼痛明显低于对照组(P值)。结论:静脉注射皮质类固醇对这种疼痛的影响已有大量研究。然而,口服皮质类固醇对扁桃体切除术后疼痛的镇痛作用尚无共识。目前的研究表明,口服强的松龙与安慰剂相比,对术后疼痛有效。
{"title":"Effect of Oral Prednisolone on Pain after Tonsillectomy with Sutures: A Randomized Clinical Trial.","authors":"Amin Shayan,&nbsp;Nezammedin Berjis,&nbsp;Sayed Mostafa Hashemi","doi":"10.4103/abr.abr_410_22","DOIUrl":"https://doi.org/10.4103/abr.abr_410_22","url":null,"abstract":"<p><strong>Background: </strong>Tonsillectomy, one of the most common otolaryngology surgeries, often results in postoperative complications such as pain and bleeding. Currently, there is no consensus on postoperative pain management. This study aimed to determine the efficacy of oral prednisolone on postoperative pain after tonsillectomy with sutures.</p><p><strong>Materials and methods: </strong>This pilot, double-blind, randomized clinical trial was conducted at two tertiary care centers affiliated with Isfahan University of Medical Sciences. Patients who underwent tonsillectomy with sutures were included. Participants were randomly divided into experimental and control groups. In the experimental group, patients received oral prednisolone in addition to acetaminophen; in the control group, patients received acetaminophen and a placebo. Post-operative pain was evaluated by a visual analog scale daily for ten days.</p><p><strong>Results: </strong>Initially, 60 patients were enrolled in the study; however, four were excluded due to non-attendance at follow-up visits. The groups were similar in terms of age and sex (both <i>P</i> values >0.05). In the study, postoperative pain from 1<sup>st</sup> day to the 10<sup>th</sup> day was lower in the experimental group than in the control group (<i>P</i> value <0.05).</p><p><strong>Conclusion: </strong>Numerous studies have been conducted on the effect of intravenous corticosteroids on this pain. However, there is no consensus on the analgesic role of oral corticosteroids for post-tonsillectomy pain. The present study showed that oral prednisolone is effective on post-operative pain compared to a placebo.</p>","PeriodicalId":7225,"journal":{"name":"Advanced Biomedical Research","volume":"12 ","pages":"202"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6e/92/ABR-12-202.PMC10492605.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10223600","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Advanced Biomedical Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1